Comparison of Two Myoepicardial Pacemaker Leads

Follow‐up in 80 Children, Adolescents, and Young Adults

John Dale Kugler, W. Monsour, C. Blodgett, J. Cheatham, Carl Herbert Gumbiner, P. Hofschire, L. Latson, W. Fleming

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Although severai types of commercially available epicardial leads exist, few postimplantation data have been reported. To compare “screw‐in” (6917–35) leads with “stab‐on” leads (4951–35) from the same manufacturer, we reviewed the records of 80 young patients (age 8 days to 29 years) who underwent ventricular epicardial pacemaker implantation from 1973 to 1986. Follow‐up for the 57 patients with the 6917–35 model ranged from 3 months to 17 years (median 6.5 years) and for the 23 patients with the 4951–35 model 9 days to 4.25 years (median 2.0 years). Actuarial life table analysis revealed significantly (P < 0.001) fewer 4951–35 leads were functioning at each of 1–5 years after implant, compared to the 6917–35 leads. Analysis of available threshold pulse width data revealed no difference (P = 0.08) acutely (6 weeks after implant), but a significantly (P = 0.05) higher mean threshold for the 4951–35 leads was found chronically. No significant correlation was found for lead failure with age, underlying heart disease, lead site (i.e., left or right ventricle), or surgical approach. Using the sutureless, stab‐on technique, the 4951–35 lead is associated with higher thresholds and lower survival rate when compared to the 6917–35 lead.

Original languageEnglish (US)
Pages (from-to)2216-2222
Number of pages7
JournalPacing and Clinical Electrophysiology
Volume11
Issue number12
DOIs
StatePublished - Jan 1 1988

Fingerprint

Young Adult
Heart Ventricles
Life Tables
Pulse
Heart Diseases
Survival Rate
Lead

Keywords

  • children
  • leads
  • myoepicardial
  • pacemaker

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Comparison of Two Myoepicardial Pacemaker Leads : Follow‐up in 80 Children, Adolescents, and Young Adults. / Kugler, John Dale; Monsour, W.; Blodgett, C.; Cheatham, J.; Gumbiner, Carl Herbert; Hofschire, P.; Latson, L.; Fleming, W.

In: Pacing and Clinical Electrophysiology, Vol. 11, No. 12, 01.01.1988, p. 2216-2222.

Research output: Contribution to journalArticle

Kugler, John Dale ; Monsour, W. ; Blodgett, C. ; Cheatham, J. ; Gumbiner, Carl Herbert ; Hofschire, P. ; Latson, L. ; Fleming, W. / Comparison of Two Myoepicardial Pacemaker Leads : Follow‐up in 80 Children, Adolescents, and Young Adults. In: Pacing and Clinical Electrophysiology. 1988 ; Vol. 11, No. 12. pp. 2216-2222.
@article{a3d1ed20a8054e44aac341f0ba15ba29,
title = "Comparison of Two Myoepicardial Pacemaker Leads: Follow‐up in 80 Children, Adolescents, and Young Adults",
abstract = "Although severai types of commercially available epicardial leads exist, few postimplantation data have been reported. To compare “screw‐in” (6917–35) leads with “stab‐on” leads (4951–35) from the same manufacturer, we reviewed the records of 80 young patients (age 8 days to 29 years) who underwent ventricular epicardial pacemaker implantation from 1973 to 1986. Follow‐up for the 57 patients with the 6917–35 model ranged from 3 months to 17 years (median 6.5 years) and for the 23 patients with the 4951–35 model 9 days to 4.25 years (median 2.0 years). Actuarial life table analysis revealed significantly (P < 0.001) fewer 4951–35 leads were functioning at each of 1–5 years after implant, compared to the 6917–35 leads. Analysis of available threshold pulse width data revealed no difference (P = 0.08) acutely (6 weeks after implant), but a significantly (P = 0.05) higher mean threshold for the 4951–35 leads was found chronically. No significant correlation was found for lead failure with age, underlying heart disease, lead site (i.e., left or right ventricle), or surgical approach. Using the sutureless, stab‐on technique, the 4951–35 lead is associated with higher thresholds and lower survival rate when compared to the 6917–35 lead.",
keywords = "children, leads, myoepicardial, pacemaker",
author = "Kugler, {John Dale} and W. Monsour and C. Blodgett and J. Cheatham and Gumbiner, {Carl Herbert} and P. Hofschire and L. Latson and W. Fleming",
year = "1988",
month = "1",
day = "1",
doi = "10.1111/j.1540-8159.1988.tb05988.x",
language = "English (US)",
volume = "11",
pages = "2216--2222",
journal = "PACE - Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Comparison of Two Myoepicardial Pacemaker Leads

T2 - Follow‐up in 80 Children, Adolescents, and Young Adults

AU - Kugler, John Dale

AU - Monsour, W.

AU - Blodgett, C.

AU - Cheatham, J.

AU - Gumbiner, Carl Herbert

AU - Hofschire, P.

AU - Latson, L.

AU - Fleming, W.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Although severai types of commercially available epicardial leads exist, few postimplantation data have been reported. To compare “screw‐in” (6917–35) leads with “stab‐on” leads (4951–35) from the same manufacturer, we reviewed the records of 80 young patients (age 8 days to 29 years) who underwent ventricular epicardial pacemaker implantation from 1973 to 1986. Follow‐up for the 57 patients with the 6917–35 model ranged from 3 months to 17 years (median 6.5 years) and for the 23 patients with the 4951–35 model 9 days to 4.25 years (median 2.0 years). Actuarial life table analysis revealed significantly (P < 0.001) fewer 4951–35 leads were functioning at each of 1–5 years after implant, compared to the 6917–35 leads. Analysis of available threshold pulse width data revealed no difference (P = 0.08) acutely (6 weeks after implant), but a significantly (P = 0.05) higher mean threshold for the 4951–35 leads was found chronically. No significant correlation was found for lead failure with age, underlying heart disease, lead site (i.e., left or right ventricle), or surgical approach. Using the sutureless, stab‐on technique, the 4951–35 lead is associated with higher thresholds and lower survival rate when compared to the 6917–35 lead.

AB - Although severai types of commercially available epicardial leads exist, few postimplantation data have been reported. To compare “screw‐in” (6917–35) leads with “stab‐on” leads (4951–35) from the same manufacturer, we reviewed the records of 80 young patients (age 8 days to 29 years) who underwent ventricular epicardial pacemaker implantation from 1973 to 1986. Follow‐up for the 57 patients with the 6917–35 model ranged from 3 months to 17 years (median 6.5 years) and for the 23 patients with the 4951–35 model 9 days to 4.25 years (median 2.0 years). Actuarial life table analysis revealed significantly (P < 0.001) fewer 4951–35 leads were functioning at each of 1–5 years after implant, compared to the 6917–35 leads. Analysis of available threshold pulse width data revealed no difference (P = 0.08) acutely (6 weeks after implant), but a significantly (P = 0.05) higher mean threshold for the 4951–35 leads was found chronically. No significant correlation was found for lead failure with age, underlying heart disease, lead site (i.e., left or right ventricle), or surgical approach. Using the sutureless, stab‐on technique, the 4951–35 lead is associated with higher thresholds and lower survival rate when compared to the 6917–35 lead.

KW - children

KW - leads

KW - myoepicardial

KW - pacemaker

UR - http://www.scopus.com/inward/record.url?scp=0024205546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024205546&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8159.1988.tb05988.x

DO - 10.1111/j.1540-8159.1988.tb05988.x

M3 - Article

VL - 11

SP - 2216

EP - 2222

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 12

ER -